XML 99 R5.htm IDEA: XBRL DOCUMENT v2.4.0.6
Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Dec. 31, 2011
Dec. 31, 2010
Dec. 31, 2009
Cash flows from operating activities      
Net income $ 199,389 $ 91,874 $ 189,660
Adjustments to reconcile net income to net cash provided by operating activities:      
Amortization of convertible notes offering costs 5,386 1,682 2,159
Amortization of non-recourse notes offering costs 4,533 7,238 1,256
Other amortization and depreciation expense 1,405 330 991
Loss (gain) on retirement or conversion of convertible notes 766 17,648 (1,518)
Stock-based compensation expense 387 662 821
Tax benefit (expense) from stock-based compensation arrangements (120) 12,818 64,140
Net excess tax benefit from stock-based compensation   (12,924) (70,610)
Deferred income taxes 31,217 (5,677) 10,242
Changes in assets and liabilities:      
Receivables from licensees (131) 581 12,450
Prepaid and other current assets (199) 1,445 (4,903)
Other assets (6,639) 182  
Accounts payable (2,012) 2,170 (1,347)
Accrued legal settlement (37,500) 65,000  
Accrued liabilities 239 (26,229) (16,387)
Other long-term liabilities (26,939) 27,500  
Net cash provided by operating activities 169,782 184,300 186,954
Cash flows from investing activities      
Purchases of investments (74,744) (46,668)  
Maturities of investments 50,696 9,772 15,000
Purchase of property and equipment     (39)
Release of restricted cash     3,469
Net cash provided by (used in) investing activities (24,048) (36,896) 18,430
Cash flows from financing activities      
Retirement of convertible notes (133,851) (108,247) (69,953)
Repayment of non-recourse notes (110,900) (95,730)  
Net proceeds from the issuance of convertible notes 149,712 82,039  
Net proceeds from the issuance of non-recourse notes     285,746
Purchase of call options (20,765)    
Proceeds from issue of warrants 10,868    
Cash dividends paid (83,828) (130,043) (319,020)
Excess tax benefit from stock-based compensation   12,924 70,610
Proceeds from issuance of common stock, net of cancellations     1,402
Net cash used in financing activities (188,764) (239,057) (31,215)
Net increase (decrease) in cash and cash equivalents (43,030) (91,653) 174,169
Cash and cash equivalents at beginning of the year 211,574 303,227 129,058
Cash and cash equivalents at end the year 168,544 211,574 303,227
Supplemental cash flow information      
Cash paid for income taxes 83,000 69,000 29,258
Cash paid for interest 25,627 40,622 11,552
Supplemental disclosures of non-cash financing activities      
Conversion of convertible notes   $ 111,680